Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities
PURPOSE OF REVIEW: The COVID-19 pandemic has forced many center-based cardiac rehabilitation (CBCR) programs to close or limit their usual offerings. In order for patients to continue to benefit from CR, programs need to rapidly adapt to the current environment. This review highlights ways CR has ev...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947942/ https://www.ncbi.nlm.nih.gov/pubmed/33704611 http://dx.doi.org/10.1007/s11886-021-01482-7 |
_version_ | 1783663333322260480 |
---|---|
author | Epstein, Elizabeth Patel, Neeja Maysent, Kathryn Taub, Pam R. |
author_facet | Epstein, Elizabeth Patel, Neeja Maysent, Kathryn Taub, Pam R. |
author_sort | Epstein, Elizabeth |
collection | PubMed |
description | PURPOSE OF REVIEW: The COVID-19 pandemic has forced many center-based cardiac rehabilitation (CBCR) programs to close or limit their usual offerings. In order for patients to continue to benefit from CR, programs need to rapidly adapt to the current environment. This review highlights ways CR has evolved, and reviews the history of CR and recent advancements in telemedicine including remote patient monitoring, and mobile health that can be applied to CR. RECENT FINDINGS: Despite that initial studies indicate that home-based CR (HBCR) is safe and effective, HBCR has faced several challenges that have prevented it from becoming more widely implemented. Many previous concerns can now be addressed through the use of new innovations in home-based healthcare delivery. SUMMARY: Since its inception, CR has become increasingly recognized as an important tool to improve patient mortality and quality of life in a broad range of cardiac diseases. While there has been little need to modify the delivery of CR since the 1950s, COVID-19 now serves as the necessary impetus to make HBCR an equal alternative to CBCR. |
format | Online Article Text |
id | pubmed-7947942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79479422021-03-11 Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities Epstein, Elizabeth Patel, Neeja Maysent, Kathryn Taub, Pam R. Curr Cardiol Rep Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor) PURPOSE OF REVIEW: The COVID-19 pandemic has forced many center-based cardiac rehabilitation (CBCR) programs to close or limit their usual offerings. In order for patients to continue to benefit from CR, programs need to rapidly adapt to the current environment. This review highlights ways CR has evolved, and reviews the history of CR and recent advancements in telemedicine including remote patient monitoring, and mobile health that can be applied to CR. RECENT FINDINGS: Despite that initial studies indicate that home-based CR (HBCR) is safe and effective, HBCR has faced several challenges that have prevented it from becoming more widely implemented. Many previous concerns can now be addressed through the use of new innovations in home-based healthcare delivery. SUMMARY: Since its inception, CR has become increasingly recognized as an important tool to improve patient mortality and quality of life in a broad range of cardiac diseases. While there has been little need to modify the delivery of CR since the 1950s, COVID-19 now serves as the necessary impetus to make HBCR an equal alternative to CBCR. Springer US 2021-03-11 2021 /pmc/articles/PMC7947942/ /pubmed/33704611 http://dx.doi.org/10.1007/s11886-021-01482-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor) Epstein, Elizabeth Patel, Neeja Maysent, Kathryn Taub, Pam R. Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title | Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title_full | Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title_fullStr | Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title_full_unstemmed | Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title_short | Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities |
title_sort | cardiac rehab in the covid era and beyond: mhealth and other novel opportunities |
topic | Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947942/ https://www.ncbi.nlm.nih.gov/pubmed/33704611 http://dx.doi.org/10.1007/s11886-021-01482-7 |
work_keys_str_mv | AT epsteinelizabeth cardiacrehabinthecovideraandbeyondmhealthandothernovelopportunities AT patelneeja cardiacrehabinthecovideraandbeyondmhealthandothernovelopportunities AT maysentkathryn cardiacrehabinthecovideraandbeyondmhealthandothernovelopportunities AT taubpamr cardiacrehabinthecovideraandbeyondmhealthandothernovelopportunities |